Publications in collaboration with researchers from Hospital Universitario de Cruces (18)

2023

  1. Proposal for updating the Health Assessment Questionnaire

    Reumatologia Clinica, Vol. 19, Núm. 5, pp. 266-272

2019

  1. Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality

    RMD Open, Vol. 5, Núm. 2

2017

  1. Weight loss for overweight and obese individuals with gout: A systematic review of longitudinal studies

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 11, pp. 1870-1882

2016

  1. Epidemiology and health-related services

    Current Opinion in Rheumatology, Vol. 28, Núm. 2, pp. 104-109

2015

  1. Consensus of the Spanish society of pediatric rheumatology for transition management from pediatric to adult care in rheumatic patients with childhood onset

    Rheumatology International, Vol. 35, Núm. 10, pp. 1615-1624

  2. Erratum to Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis (Rheumatol Int, (2015), 10.1007/s00296-014-3189-6)

    Rheumatology International

  3. Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis

    Rheumatology International, Vol. 35, Núm. 7, pp. 1127-1137

2014

  1. Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 1, pp. 177-182

2012

  1. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223

  2. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2163-2196

2011

  1. A two-stage approach to the treatment of hyperuricemia in gout: The "dirty Dish" hypothesis

    Arthritis and Rheumatism, Vol. 63, Núm. 12, pp. 4002-4006

  2. An audit of the variability of diagnosis and management of gout in the rheumatology setting: The gout evaluation and management study

    Journal of Clinical Rheumatology, Vol. 17, Núm. 7, pp. 349-355

2008

  1. Burden of disease across chronic diseases: A health survey that measured prevalence, function, and quality of life

    Journal of Rheumatology, Vol. 35, Núm. 1, pp. 159-165

  2. Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: Results from a natiowide study in Spain

    Clinical and Experimental Rheumatology, Vol. 26, Núm. 4, pp. 519-526

  3. Prevalence, risk factors, and impact of knee pain suggesting osteoarthritis in Spain

    Clinical and Experimental Rheumatology, Vol. 26, Núm. 2, pp. 324-332

  4. Reacciones adversas relacionadas con la administración de inhibidores del TNF. Análisis de un registro de terapias biológicas

    Reumatologia Clinica, Vol. 4, Núm. 3, pp. 90-95

2006

  1. Basic principles and evidence on antidepressants and anticonvulsants in rheumatic pain

    Reumatologia Clinica, Vol. 2, Núm. SPEC. ISS. 1, pp. 18-22

  2. Switching TNF antagonists in patients with chronic arthritis: An observational study of 488 patients over a four-year period

    Arthritis Research and Therapy, Vol. 8, Núm. 1